Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
61.8M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
+2.8M
-
Total reported value, excl. options
-
$759M
-
Value change
-
+$60.7M
-
Number of buys
-
32
-
Number of sells
-
-33
-
Price
-
$22.28
Significant Holders of Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) as of Q3 2021
74 filings reported holding GLUE - Monte Rosa Therapeutics, Inc. - COMMON STOCK as of Q3 2021.
Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 61.8M outstanding shares and own 56.43% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (7.7M shares), FMR LLC (6.96M shares), Avoro Capital Advisors LLC (3.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.15M shares), Cormorant Asset Management, LP (3.1M shares), BlackRock Inc. (2.07M shares), Aisling Capital Management LP (1.47M shares), Alphabet Inc. (1.46M shares), RTW INVESTMENTS, LP (1.21M shares), and VANGUARD GROUP INC (1.02M shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.